Literature DB >> 24555473

Chromatin contributions to the regulation of innate immunity.

Stephen T Smale1, Alexander Tarakhovsky, Gioacchino Natoli.   

Abstract

A fundamental property of cells of the innate immune system is their ability to elicit a transcriptional response to a microbial stimulus or danger signal with a high degree of cell type and stimulus specificity. The selective response activates effector pathways to control the insult and plays a central role in regulating adaptive immunity through the differential regulation of cytokine genes. Selectivity is dictated by signaling pathways and their transcription factor targets. However, a growing body of evidence supports models in which different subsets of genes exhibit distinct chromatin features that play active roles in shaping the response. Chromatin also participates in innate memory mechanisms that can promote tolerance to a stimulus or prime cells for a more robust response. These findings have generated interest in the capacity to modulate chromatin regulators with small-molecule compounds for the treatment of diseases associated with innate or adaptive immunity.

Mesh:

Substances:

Year:  2014        PMID: 24555473     DOI: 10.1146/annurev-immunol-031210-101303

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  71 in total

1.  New insights into the multidimensional concept of macrophage ontogeny, activation and function.

Authors:  Florent Ginhoux; Joachim L Schultze; Peter J Murray; Jordi Ochando; Subhra K Biswas
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

Review 2.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

Review 3.  Eukaryotic enhancers: common features, regulation, and participation in diseases.

Authors:  Maksim Erokhin; Yegor Vassetzky; Pavel Georgiev; Darya Chetverina
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

Review 4.  IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.

Authors:  Lionel B Ivashkiv
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 53.106

Review 5.  Recent advances in vertebrate and invertebrate transgenerational immunity in the light of ecology and evolution.

Authors:  Olivia Roth; Anne Beemelmanns; Seth M Barribeau; Ben M Sadd
Journal:  Heredity (Edinb)       Date:  2018-06-18       Impact factor: 3.821

6.  Interferon stimulation creates chromatin marks and establishes transcriptional memory.

Authors:  Rui Kamada; Wenjing Yang; Yubo Zhang; Mira C Patel; Yanqin Yang; Ryota Ouda; Anup Dey; Yoshiyuki Wakabayashi; Kazuyasu Sakaguchi; Takashi Fujita; Tomohiko Tamura; Jun Zhu; Keiko Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-10       Impact factor: 11.205

Review 7.  Transcriptional and epigenetic networks of helper T and innate lymphoid cells.

Authors:  Han-Yu Shih; Giuseppe Sciumè; Amanda C Poholek; Golnaz Vahedi; Kiyoshi Hirahara; Alejandro V Villarino; Michael Bonelli; Remy Bosselut; Yuka Kanno; Stefan A Muljo; John J O'Shea
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

Review 8.  Diversity, Mechanisms, and Significance of Macrophage Plasticity.

Authors:  Massimo Locati; Graziella Curtale; Alberto Mantovani
Journal:  Annu Rev Pathol       Date:  2019-09-17       Impact factor: 23.472

9.  Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages.

Authors:  Ana Ramón-Vázquez; Juan Vladimir de la Rosa; Carlos Tabraue; Felix Lopez; Bonifacio Nicolas Díaz-Chico; Lisardo Bosca; Peter Tontonoz; Susana Alemany; Antonio Castrillo
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

Review 10.  Transcription factor mutations as a cause of familial myeloid neoplasms.

Authors:  Jane E Churpek; Emery H Bresnick
Journal:  J Clin Invest       Date:  2019-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.